FDA ANDA · ANDA076218

LATANOPROST

Sponsor: PAR PHARM

APPLICATION

ANDA076218

TYPE

ANDA

ROUTE

OPHTHALMIC

DOSAGE FORM

SOLUTION

MARKETING STATUS

None (Tentative Approval)

Products

LATANOPROSTNone (Tentative Approval)

LATANOPROST 0.005% · SOLUTION · OPHTHALMIC

2007-03-09OriginalTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.